You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DS1062a

Showing 1 - 25 of 8,043
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hormone Receptor Positive Breast Cancer, Triple Negative Breast Cancer, NSCLC Trial in Japan, United States (Datopotamab

Recruiting
  • Hormone Receptor Positive Breast Cancer
  • +2 more
  • Datopotamab Deruxtecan (Dato-DXd)
  • Los Angeles, California
  • +13 more
Jun 21, 2022

Metastatic Lung Cancer Trial in Villejuif (DS-1062a)

Recruiting
  • Metastatic Lung Cancer
  • Villejuif, France
    Gustave Roussy
Jun 17, 2021

Breast Cancer Stage IV Trial in Vienna (Datopotamab deruxtecan)

Recruiting
  • Breast Cancer Stage IV
  • Datopotamab deruxtecan
  • Vienna, Austria
    AKH Universitaetsklinikum Vienna, Department f. Internal medicin
May 19, 2023

NSCLC, Triple Negative Breast Cancer Trial in China (Datopotamab Deruxtecan (Dato-DXd))

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Triple Negative Breast Cancer
  • Datopotamab Deruxtecan (Dato-DXd)
  • Beijing, China
  • +27 more
Aug 11, 2022

NSCLC Trial in Worldwide (DS-1062a)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Phoenix, Arizona
  • +82 more
Jul 27, 2022

NSCLC Trial in Worldwide (Osimertinib, Savolitinib, Gefitinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Duarte, California
  • +52 more
Jan 19, 2023

Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan

Not yet recruiting
  • Endometrial Cancer
  • +4 more
  • Datopotamab deruxtecan (Dato-DXd)
  • +8 more
  • Los Angeles, California
  • +52 more
Aug 3, 2022

Advanced Solid Tumor Trial in Chiba, Tokyo (DS-1471a)

Recruiting
  • Advanced Solid Tumor
  • Chiba, Japan
  • +1 more
Oct 5, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial (DS-3939a)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
May 12, 2023

Cholangioscopy With Spyglass DS Using Percutaneous Transhepatic

Completed
  • Biliary Stricture
  • Spy PTC
  • (no location specified)
Oct 17, 2023

Advanced Solid Tumor, Breast Cancer Trial in Atlanta (DS-1103a, T-DXd)

Not yet recruiting
  • Advanced Solid Tumor
  • Breast Cancer
  • Atlanta, Georgia
    Emory University School of Medicine
Mar 1, 2023

Netherton Syndrome Trial in Paris (DS-2325a, Placebo)

Not yet recruiting
  • Netherton Syndrome
  • Paris, France
    Saint Louis Hospital
Jul 31, 2023

Atopic Dermatitis Trial in Worldwide (DS107, Placebo)

Terminated
Has Results
  • Atopic Dermatitis
  • Birmingham, Alabama
  • +49 more
Nov 3, 2022

NSCLC Trial in Worldwide (DS-1062a, Docetaxel)

Recruiting
  • Non-small Cell Lung Cancer
  • Chandler, Arizona
  • +203 more
Jun 9, 2022

Malignant Solid Tumor, Metastatic EphA2 Positive Cancer Trial in Heidelberg (DS-8895a 1 mg/kg, DS-8895a 3 mg/kg, DS-8895a 10

Completed
Has Results
  • Malignant Solid Tumor
  • Metastatic EphA2 Positive Cancer
  • DS-8895a 1 mg/kg
  • +2 more
  • Heidelberg, Victoria, Australia
    Austin Health
Oct 3, 2022

Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Duarte, California
  • +111 more
Oct 23, 2023

Netherton Syndrome Trial in San Antonio (DS-2325a, Placebo)

Recruiting
  • Netherton Syndrome
  • San Antonio, Texas
    Worldwide Clinical Trials
Nov 29, 2022

Breast Cancer, Metastatic Breast Cancer Trial (Trastuzumab-Deruxtecan (T-DXd))

Not yet recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • Trastuzumab-Deruxtecan (T-DXd)
  • (no location specified)
Sep 20, 2023

Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus Trial (DS-7011a, Placebo)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Cutaneous Lupus Erythematosus
  • (no location specified)
Dec 12, 2022

Diabetes, Diabetic Retinopathy Trial in Fayetteville, Orlando, Jackson (AEYE-DS Software)

Recruiting
  • Diabetes Mellitus
  • Diabetic Retinopathy
  • AEYE-DS Software
  • Fayetteville, Arkansas
  • +2 more
May 4, 2023

Netherton Syndrome Trial in Miami (DS-2325a, Placebo)

Recruiting
  • Netherton Syndrome
  • Miami, Florida
    Quotient Sciences -Miami
Nov 8, 2022

Endometrial Serous Adenocarcinoma, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States

Recruiting
  • Endometrial Serous Adenocarcinoma
  • +2 more
  • Biopsy
  • +3 more
  • Phoenix, Arizona
  • +3 more
Feb 2, 2023

Covid19 Trial in Hakata (DS-5670a, Placebo)

Completed
  • Covid19
  • DS-5670a
  • Placebo
  • Hakata, Fukuoka, Japan
    SOUSEIKAI Hakata Clinic
Aug 29, 2022

Adenocarcinoma, Gastric, Tumor, Breast Trial in Taipei (DS-8201a)

Completed
Has Results
  • Adenocarcinoma, Gastric
  • Neoplasm, Breast
  • Taipei, Taiwan
  • +1 more
Nov 2, 2022

Fibrodysplasia Ossificans Progressiva Trial in Osaka (DS-6016a, Placebo)

Completed
  • Fibrodysplasia Ossificans Progressiva
  • Osaka, Japan
    Medical Corporation Heishinkai OPHAC Hospital
Aug 2, 2022